divesting others over recent years, Baxter International (NYSE: BAX ) has decided to split into two ..... healthcare companies in mid-2015. BAX recently exceeded third quarter ..... analyst concerns about the ability of BAX 's hemophilia business to compete
June, I wrote a bullish article on Baxter (NYSE: BAX ), with a thesis stating that the ..... also stated that the expansion of Baxter 's ADVATE program into emerging ..... there are underlying risks to a Baxter investment, as the company has reeled
By SA Transcripts : Baxter International Inc . (NYSE: BAX ) Q3 2014 Results Earnings ..... gentlemen and welcome to the Baxter International ’s, third quarter earnings ..... call is being recorded by Baxter and is copyrighted material
By SA Transcripts : The following audio is from a conference call that will begin on October 16, 2014 at 08:30 AM ET. The audio will stream live while the call is active, and can be replayed upon its completion. Listen now If you would like to view a transcript of this call, please click here. ...
Baxter International (NYSE: BAX ) Q3 results ($M): Total Revenues: 4,251 (+12.6%); U.S.: 1,755 (+6.9%); International: 2,442
Oct 16 (Reuters) - Medical device and drug maker Baxter International Inc reported a higher-than-expected quarterly profit, as sales in its medical products business continued to grow.
value estimate for Baxter after third-quarter results. Baxter 's revenue (excluding the vaccine business, which ..... 32. Overall, Baxter 's hemophilia franchise ..... example, Baxalta ( Baxter 's BioScience spin ..... proteins. The new Baxter stands to benefit ..... Biosurgery and Specialty Pharmaceuticals .
Oct 16 (Reuters) - Medical device and drug maker Baxter International Inc reported a higher-than-expected quarterly profit, as sales at its medical products business continued to grow.
Baxter (NYSE: BAX ): Q3 EPS of $1.35 beats by $0.04 . Revenue of $4.20B (+13.2% Y/Y) in-line. Press Release Post your comment!
announced an exclusive agreement with Baxter International (NYSE: BAX ) to commercialize Rockwell ..... receive $20 million in cash and Baxter will purchase $15 million in ..... initial term is 10 years and Baxter can extend the agreement for